Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04920383
Title ALPN-202 With PD-1 Inhibition in Advanced Malignancies (NEON-2)
Acronym NEON-2
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alpine Immune Sciences, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Investigational Site (213) Atlanta Georgia 30322 United States Details
Investigational Site (212) Boston Massachusetts 02114 United States Details
Investigational Site (301) Grand Rapids Michigan 49546 United States Details
Investigational Site (203) Nashville Tennessee 37203 United States Details
Investigational Site (215) San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field